AGER and Myocardial fibrosis: In myocardial fibrosis, chronic hyperglycemia promotes myocardial fibroblast proliferation and abnormal collagen deposition through the activation of the advanced glycation end-product-receptor axis and the transforming growth factor-β/Smad signaling pathway, leading to increased myocardial stiffness and diastolic dysfunction [52,53].